BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24107735)

  • 1. Geometry-independent inclusion of basal myocardium yields improved cardiac magnetic resonance agreement with echocardiography and necropsy quantified left-ventricular mass.
    Simprini LA; Goyal P; Codella N; Fieno DS; Afroz A; Mullally J; Cooper M; Wang Y; Finn JP; Devereux RB; Weinsaft JW
    J Hypertens; 2013 Oct; 31(10):2069-76. PubMed ID: 24107735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved left ventricular mass quantification with partial voxel interpolation: in vivo and necropsy validation of a novel cardiac MRI segmentation algorithm.
    Codella NC; Lee HY; Fieno DS; Chen DW; Hurtado-Rua S; Kochar M; Finn JP; Judd R; Goyal P; Schenendorf J; Cham MD; Devereux RB; Prince M; Wang Y; Weinsaft JW
    Circ Cardiovasc Imaging; 2012 Jan; 5(1):137-46. PubMed ID: 22104165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Three-dimensional analysis of left ventricular geometry using magnetic resonance imaging: feasibility and comparison with echocardiographic analysis].
    Moriuchi M; Saito S; Kasamaki Y; Komaki K; Kanmatsuse K; Hayasaka K
    J Cardiol; 2003 Dec; 42(6):249-60. PubMed ID: 14723017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular mass and systolic function in children with chronic kidney disease-comparing echocardiography with cardiac magnetic resonance imaging.
    Arnold R; Schwendinger D; Jung S; Pohl M; Jung B; Geiger J; Gimpel C
    Pediatr Nephrol; 2016 Feb; 31(2):255-65. PubMed ID: 26342304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between maximal left ventricular wall thickness and left ventricular mass in patients with hypertrophic cardiomyopathy.
    Spiewak M; Chojnowska L; Małek LA; Miłosz B; Petryka J; Zabicka M; Kłopotowski M; Dabrowski M; Miśko J; Ruzyłło W
    Kardiol Pol; 2010 Jul; 68(7):763-8. PubMed ID: 20648432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of 2-dimensional echocardiography vs cardiac magnetic resonance imaging in measuring left ventricular mass in patients with and without end-stage renal disease.
    Jakubovic BD; Wald R; Goldstein MB; Leong-Poi H; Yuen DA; Perl J; Lima JA; Liu JJ; Kirpalani A; Dacouris N; Wald R; Connelly KA; Yan AT
    Can J Cardiol; 2013 Mar; 29(3):384-90. PubMed ID: 23103220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Real Time 3D Echocardiography for the Assessment of Left Ventricular Mass in Patients with Hypertrophic Cardiomyopathy: Comparison with Cardiac Magnetic Resonance.
    Avegliano GP; Costabel JP; Asch FM; Sciancalepore A; Kuschnir P; Huguet M; Tobon-Gomez C; Frangi AF; Ronderos R
    Echocardiography; 2016 Mar; 33(3):431-6. PubMed ID: 26525462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of left ventricular mass by transthoracic three-dimensional echocardiography in patients with dilated cardiomyopathy].
    Geil S; Rao L; Menzel T; Genth-Zotz S; Wittlinger T; Voigtländer T; Mohr-Kahaly S
    Z Kardiol; 1999 Nov; 88(11):922-31. PubMed ID: 10643060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular mass and hypertrophy by echocardiography and cardiac magnetic resonance: the multi-ethnic study of atherosclerosis.
    Armstrong AC; Gjesdal O; Almeida A; Nacif M; Wu C; Bluemke DA; Brumback L; Lima JA
    Echocardiography; 2014; 31(1):12-20. PubMed ID: 23930739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of left ventricular mass and concentric remodeling to extent of coronary artery disease by computed tomography in patients without left ventricular hypertrophy: ROMICAT study.
    Truong QA; Toepker M; Mahabadi AA; Bamberg F; Rogers IS; Blankstein R; Brady TJ; Nagurney JT; Hoffmann U
    J Hypertens; 2009 Dec; 27(12):2472-82. PubMed ID: 19696685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excessive increase in left ventricular mass identifies hypertensive subjects with clustered geometric and functional abnormalities.
    Chinali M; De Marco M; D'Addeo G; Benincasa M; Romano C; Galderisi M; de Simone G
    J Hypertens; 2007 May; 25(5):1073-8. PubMed ID: 17414672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular mass estimation by real-time 3D echocardiography favourably competes with CMR in congenital left ventricular disease.
    Michel M; Shabanah W; Körperich H; Kelter-Klöpping A; Entenmann A; Racolta A; Laser KT
    Sci Rep; 2019 Aug; 9(1):11888. PubMed ID: 31417137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study.
    Velagaleti RS; Gona P; Chuang ML; Salton CJ; Fox CS; Blease SJ; Yeon SB; Manning WJ; O'Donnell CJ
    Circ Cardiovasc Imaging; 2010 May; 3(3):257-63. PubMed ID: 20208015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
    Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
    Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients.
    Perticone F; Maio R; Ceravolo R; Cosco C; Cloro C; Mattioli PL
    Circulation; 1999 Apr; 99(15):1991-6. PubMed ID: 10209003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transthoracic three-dimensional echocardiography for determination of left ventricular mass in patients with dilated cardiomyopathy].
    Rao L; Geil S; Zeng Z; Tang H; Zhang Q; Huang D
    Hua Xi Yi Ke Da Xue Xue Bao; 2000 Sep; 31(3):376-9. PubMed ID: 12545839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved method for automatic segmentation of the left ventricle in myocardial perfusion SPECT.
    Soneson H; Ubachs JF; Ugander M; Arheden H; Heiberg E
    J Nucl Med; 2009 Feb; 50(2):205-13. PubMed ID: 19164235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Left Ventricular Mass and Hypertrophy by Cardiovascular Magnetic Resonance Imaging in Pediatric Hypertension.
    Supe-Markovina K; Nielsen JC; Musani M; Panesar LE; Woroniecki RP
    J Clin Hypertens (Greenwich); 2016 Oct; 18(10):976-981. PubMed ID: 26988578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of left ventricular mass between two-dimensional echocardiography, using fundamental and tissue harmonic imaging, and cardiac MRI in patients with hypertension.
    Alfakih K; Bloomer T; Bainbridge S; Bainbridge G; Ridgway J; Williams G; Sivananthan M
    Eur J Radiol; 2004 Nov; 52(2):103-9. PubMed ID: 15489067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid and accurate left ventricular chamber quantification using a novel CMR segmentation algorithm: a clinical validation study.
    Codella NC; Cham MD; Wong R; Chu C; Min JK; Prince MR; Wang Y; Weinsaft JW
    J Magn Reson Imaging; 2010 Apr; 31(4):845-53. PubMed ID: 20373428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.